“Collectively, the new data presented at EHA showcase the robust activity observed with revumenib across multiple acute leukemia subtypes and settings, highlighting the potential for revumenib to ...
The latest update is out from BioInvent International AB ( (SE:BINV)). BioInvent International will host two Key Opinion Leader events to showcase scientific and clinical advances in its oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results